On March 13, 2026, Xenon Pharmaceuticals Inc. filed an 8-K report detailing the date and record information for its 2026 annual meeting of shareholders. The meeting is scheduled for June 2, 2026, with a record date of April 7, 2026, for voting and notice purposes. This filing is part of the company's compliance with regulatory requirements and does not indicate any significant changes or events that would impact the stock price.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.